The MarketReader Minute
π Alnylam Surges, Gilead Sciences +10.5% MoM | Biotech Sector Insights
Positive developments such as successful clinical trials and FDA approvals drove stocks like Alnylam Pharmaceuticals Inc, Argenx SE, and Gilead Sciences Inc stock price increases.